Item 1.
Financial Statements (Unaudited)
MSD
ACQUISITION CORP.
UNAUDITED CONDENSED BALANCE SHEET
MARCH
31, 2021
Assets
|
|
|
|
Current assets:
|
|
|
|
Cash
|
|
$
|
1,802,020
|
|
Prepaid expenses
|
|
|
915,898
|
|
Total current assets
|
|
|
2,717,918
|
|
Investments held in Trust Account
|
|
|
575,000,396
|
|
Total Assets
|
|
$
|
577,718,314
|
|
|
|
|
|
|
Liabilities and Shareholders’ Equity:
|
|
|
|
|
Current liabilities:
|
|
|
|
|
Accounts payable
|
|
$
|
944,458
|
|
Accrued expenses
|
|
|
74,833
|
|
Advance from related party
|
|
|
22,760
|
|
Total current liabilities
|
|
|
1,042,051
|
|
Deferred underwriting commissions
|
|
|
20,125,000
|
|
Forward purchase liabilities
|
|
|
791,800
|
|
Derivative liabilities
|
|
|
23,604,200
|
|
Total liabilities
|
|
|
45,563,051
|
|
|
|
|
|
|
Commitments and Contingencies
|
|
|
|
|
|
|
|
|
|
Class A ordinary shares, $0.0001 par value; 52,715,526 shares subject to possible redemption at $10.00 per share
|
|
|
527,155,260
|
|
|
|
|
|
|
Shareholders’ Equity
|
|
|
|
|
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding
|
|
|
-
|
|
Class A ordinary shares, $0.0001 par value; 500,000,000 shares authorized; 4,784,474 shares issued and outstanding (excluding 52,715,526 shares subject to possible redemption)
|
|
|
478
|
|
Class B ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 14,375,000 shares issued and outstanding
|
|
|
1,438
|
|
Additional paid-in capital
|
|
|
7,968,723
|
|
Accumulated deficit
|
|
|
(2,970,636
|
)
|
Total shareholders’ equity
|
|
|
5,000,003
|
|
Total Liabilities and Shareholders’ Equity
|
|
$
|
577,718,314
|
|
The
accompanying notes are an integral part of these unaudited condensed financial statements.
MSD
ACQUISITION CORP.
UNAUDITED CONDENSED STATEMENT OF OPERATIONS
For
the period from February 5, 2021 (inception) through March 31, 2021
General and administrative expenses
|
|
$
|
130,102
|
|
General and administrative expenses - related party
|
|
|
10,000
|
|
Loss from operations
|
|
|
(140,102
|
)
|
Change in fair value of derivative liabilities
|
|
|
(2,133,470
|
)
|
Offering costs associated with derivative liabilities
|
|
|
(697,460
|
)
|
Income from investments held in Trust Account
|
|
|
396
|
|
Net loss
|
|
$
|
(2,970,636
|
)
|
|
|
|
|
|
Weighted average shares outstanding of Class A ordinary shares, basic and diluted
|
|
|
57,500,000
|
|
|
|
|
|
|
Basic and diluted net income per share, Class A ordinary share
|
|
$
|
0.00
|
|
|
|
|
|
|
Weighted average shares outstanding of Class B ordinary shares, basic and diluted
|
|
|
14,375,000
|
|
|
|
|
|
|
Basic and diluted net income per share, Class B ordinary share
|
|
$
|
(0.21
|
)
|
The
accompanying notes are an integral part of these unaudited condensed financial statements.
MSD
ACQUISITION CORP.
UNAUDITED CONDENSED STATEMENT OF CHANGES IN SHAREHOLDERS’ EQUITY
For
the period from February 5, 2021 (inception) through March 31, 2021
|
|
Ordinary Shares
|
|
|
Additional
|
|
|
|
|
|
Total
|
|
|
|
Class A
|
|
|
Class B
|
|
|
Paid-in
|
|
|
Accumulated
|
|
|
Shareholders’
|
|
|
|
Shares
|
|
|
Amount
|
|
|
Shares
|
|
|
Amount
|
|
|
Capital
|
|
|
Deficit
|
|
|
Equity
|
|
Balance - February 5, 2021 (inception)
|
|
|
-
|
|
|
$
|
-
|
|
|
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
Issuance of Class B ordinary shares to Sponsor
|
|
|
-
|
|
|
|
-
|
|
|
|
14,375,000
|
|
|
|
1,438
|
|
|
|
23,562
|
|
|
|
-
|
|
|
|
25,000
|
|
Sale of units in initial public offering, less allocation to derivative warrant liabilities, gross
|
|
|
57,500,000
|
|
|
|
5,750
|
|
|
|
-
|
|
|
|
-
|
|
|
|
562,804,250
|
|
|
|
-
|
|
|
|
562,810,000
|
|
Excess cash received over the fair value of the private warrants
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
3,927,470
|
|
|
|
-
|
|
|
|
3,927,470
|
|
Offering costs
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
(31,636,571
|
)
|
|
|
-
|
|
|
|
(31,636,571
|
)
|
Shares subject to possible redemption
|
|
|
(52,715,526
|
)
|
|
|
(5,272
|
)
|
|
|
-
|
|
|
|
-
|
|
|
|
(527,149,988
|
)
|
|
|
-
|
|
|
|
(527,155,260
|
)
|
Net loss
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
(2,970,636
|
)
|
|
|
(2,970,636
|
)
|
Balance - March 31, 2021
|
|
|
4,784,474
|
|
|
$
|
478
|
|
|
|
14,375,000
|
|
|
$
|
1,438
|
|
|
$
|
7,968,723
|
|
|
$
|
(2,970,636
|
)
|
|
$
|
5,000,003
|
|
The
accompanying notes are an integral part of these unaudited condensed financial statements.
MSD
ACQUISITION CORP.
UNAUDITED CONDENSED STATEMENT OF CASH FLOWS
For
the period from February 5, 2021 (inception) through March 31, 2021
Cash Flows from Operating Activities:
|
|
|
|
Net loss
|
|
$
|
(2,970,636
|
)
|
Adjustments to reconcile net income to net cash used in operating activities:
|
|
|
|
|
General and administrative expenses paid by related party in exchange for issuance of Class B ordinary shares
|
|
|
25,000
|
|
General and administrative expenses paid by related party under promissory note
|
|
|
14,383
|
|
Change in fair value of derivative liabilities
|
|
|
2,133,470
|
|
Offering costs associated with derivative liabilities
|
|
|
697,460
|
|
Income from investments held in Trust Account
|
|
|
(396
|
)
|
Changes in operating assets and liabilities:
|
|
|
|
|
Prepaid expenses
|
|
|
(915,898
|
)
|
Accounts payable
|
|
|
944,458
|
|
Accrued expenses
|
|
|
4,833
|
|
Net cash used in operating activities
|
|
|
(67,326
|
)
|
|
|
|
|
|
Cash Flows from Investing Activities:
|
|
|
|
|
Cash deposited in Trust Account
|
|
|
(575,000,000
|
)
|
Net cash used in investing activities
|
|
|
(575,000,000
|
)
|
|
|
|
|
|
Cash Flows from Financing Activities:
|
|
|
|
|
Proceeds received from initial public offering, gross
|
|
|
575,000,000
|
|
Proceeds received from private placement
|
|
|
14,000,000
|
|
Repayment of note payable to related party
|
|
|
(191,526
|
)
|
Proceeds from advance to related party
|
|
|
22,760
|
|
Offering costs paid
|
|
|
(11,961,888
|
)
|
Net cash provided by financing activities
|
|
|
576,869,346
|
|
|
|
|
|
|
Net change in cash
|
|
|
1,802,020
|
|
|
|
|
|
|
Cash - beginning of the period
|
|
|
-
|
|
Cash - end of the period
|
|
$
|
1,802,020
|
|
|
|
|
|
|
Supplemental disclosure of noncash investing and financing activities:
|
|
|
|
|
Offering costs included in accrued expenses
|
|
$
|
70,000
|
|
Offering costs paid by related party under promissory note
|
|
$
|
177,142
|
|
Deferred underwriting commissions
|
|
$
|
20,125,000
|
|
Initial value of Class A ordinary shares subject to possible redemption
|
|
$
|
529,349,860
|
|
Change in value of Class A common shares subject to possible redemption
|
|
$
|
(2,194,600
|
)
|
The
accompanying notes are an integral part of these unaudited condensed financial statements.
MSD ACQUISITION CORP.
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
Note 1 — Description
of Organization and Business Operations
MSD Acquisition Corp. (the “Company”)
is a blank check company incorporated as a Cayman Islands exempted company on February 5, 2021. The Company was incorporated for the purpose
of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more
businesses that the Company has not yet identified (“Business Combination”).
As of March 31, 2021, the Company had not yet
commenced operations. All activity for the period from February 5, 2021 (inception) through March 31, 2021 relates to the Company’s
formation and the initial public offering (the “Initial Public Offering”), which is described below. The Company will not
generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate
non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering. The Company has selected
December 31 as its fiscal year end.
The Company’s sponsor
is MSD Sponsor Holdings, LLC, a Delaware limited liability company (“Sponsor”). The registration statement for the Company’s
Initial Public Offering was declared effective on March 24, 2021. On March 29, 2021, the Company consummated its Initial Public Offering
of 57,500,000 units (the “Units” and, with respect to the Class A ordinary shares included in the Units being offered, the
“Public Shares”), including 7,500,000 additional Units to cover over-allotments (the “Over-Allotment Units”),
at $10.00 per Unit, generating gross proceeds of $575.0 million, and incurring offering costs of approximately $33 million, of which approximately
$20.1 million was for deferred underwriting commissions (see Note 6).
Simultaneously with the
closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 9,333,333 warrants
(each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”), at a price of $1.50
per Private Placement Warrant with the Sponsor, generating gross proceeds of $14.0 million (see Note 4).
Upon the closing of Initial Public Offering and
the Private Placement, $575.0 million ($10.00 per Unit) of the net proceeds of the Initial Public Offering and certain of the proceeds
of the Private Placement were placed in a trust account (“Trust Account”) with Continental Stock Transfer & Trust Company
acting as trustee and will be invested in United States “government securities” within the meaning set forth in Section 2(a)(16)
of the Investment Company Act of 1940, as amended (the “Investment Company Act”), having a maturity of 185 days or less or
in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct
U.S. government treasury obligations, as determined by the Company, until the earlier of: (i) the completion of a Business Combination
and (ii) the distribution of the Trust Account as described below.
The Company’s management has broad discretion
with respect to the specific application of the net proceeds of its Initial Public Offering and the sale of the Private Placement Warrants,
although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The Company’s
initial Business Combination must be with one or more operating businesses or assets with a fair market value equal to at least 80% of
the net assets held in the Trust Account (excluding the deferred underwriting commissions and taxes payable on the income earned on the
Trust Account) at the time the Company signs a definitive agreement in connection with the initial Business Combination. However, the
Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the outstanding
voting securities of the target business or otherwise acquires a controlling interest in the target business sufficient for it not to
be required to register as an investment company under the Investment Company Act.
The Company will provide its holders of the Public
Shares (the “Public Shareholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion
of a Business Combination either (i) in connection with a general meeting called to approve the Business Combination or (ii) by means
of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender
offer will be made by the Company. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the
amount then in the Trust Account ($10.00 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously
released to the Company to pay its tax obligations).
MSD ACQUISITION CORP.
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
The per-share amount to be distributed to Public
Shareholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters
(as discussed in Note 6). These Public Shares were recorded at a redemption value and classified as temporary equity, in accordance with
Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing
Liabilities from Equity” (“ASC 480”). In such case, the Company will proceed with a Business Combination if the Company
has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and a majority of the shares voted are
voted in favor of the Business Combination. If a shareholder vote is not required by applicable law or stock exchange listing requirements
and the Company does not decide to hold a shareholder vote for business or other reasons, the Company will, pursuant to the amended and
restated memorandum and articles of association which will be adopted by the Company upon the consummation of the Initial Public Offering
(the “Amended and Restated Memorandum and Articles of Association”), conduct the redemptions pursuant to the tender offer
rules of the U.S. Securities and Exchange Commission (the “SEC”), and file tender offer documents with the SEC prior to completing
a Business Combination. If, however, a shareholder approval of the transactions is required by applicable law or stock exchange listing
requirements, or the Company decides to obtain shareholder approval for business or other reasons, the Company will offer to redeem shares
in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each Public
Shareholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction or whether
they were a Public Shareholder on the record date for the general meeting held to approve the proposed transaction. If the Company seeks
shareholder approval in connection with a Business Combination, the holders of the Founder Shares prior to this Initial Public Offering
(the “Initial Shareholders”) agreed to vote their Founder Shares (as defined in Note 5) and any Public Shares purchased during
or after the Initial Public Offering in favor of a Business Combination. In addition, the Initial Shareholders agreed to waive their redemption
rights with respect to their Founder Shares and Public Shares in connection with the completion of a Business Combination. In addition,
the Company agreed not to enter into a definitive agreement regarding an initial Business Combination without the prior consent of the
Sponsor.
Notwithstanding the foregoing, the Company’s
Amended and Restated Memorandum and Articles of Association will provide that a Public Shareholder, together with any affiliate of such
shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section
13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares
with respect to more than an aggregate of 15% or more of the Class A ordinary shares sold in the Initial Public Offering, without the
prior consent of the Company.
The Company’s Sponsor, officers, directors
and director nominees agreed not to propose an amendment to the Company’s Amended and Restated Memorandum and Articles of Association
(A) to modify the substance or timing of the Company’s obligation to allow the redemption of its Public Shares in connection with
a Business Combination or to redeem 100% of its Public Shares if the Company does not complete a Business Combination within 24 months
from the closing of the Initial Public Offering, or March 29, 2023 (the “Combination Period”), or (B) with respect to any
other provisions relating to shareholders’ rights or pre-initial business combination activity, unless the Company provides the
Public Shareholders with the opportunity to redeem their Class A ordinary shares in conjunction with any such amendment.
If the Company is unable to complete a Business
Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly
as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash,
equal to the aggregate amount then on deposit in the Trust Account, including interest (which interest shall be net of taxes payable and
up to $100,000 of interest to pay dissolution expenses), divided by the number of then issued and outstanding Public Shares, which redemption
will completely extinguish Public Shareholders’ rights as shareholders (including the right to receive further liquidation distributions,
if any) and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders
and the board of directors, liquidate and dissolve, subject, in the case of clauses (ii) and (iii), to the Company’s obligations
under Cayman Islands law to provide for claims of creditors and in all cases subject to the other requirements of applicable law.
In connection with the redemption of 100% of the
Company’s outstanding Public Shares for a portion of the funds held in the Trust Account, each holder will receive a full pro rata
portion of the amount then in the Trust Account, plus any pro rata interest earned on the funds held in the Trust Account and not previously
released to the Company to pay the Company’s taxes payable (less taxes payable and up to $100,000 of interest to pay dissolution
expenses).
MSD ACQUISITION CORP.
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
The Initial Shareholders agreed to waive their
liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period.
However, if the Initial Shareholders should acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating
distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within
the Combination Period. The underwriters agreed to waive their rights to their deferred underwriting commission (see Note 6) held in the
Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such
amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Company’s
Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for
distribution in the Trust Account will be less than the $10.00 per share initially held in the Trust Account. In order to protect the
amounts held in the Trust Account, the Sponsor agreed that it will be liable to the Company if and to the extent any claims by a third
party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into
a written letter of intent, confidentiality or other similar agreement or business combination agreement, reduce the amount of funds in
the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account
as of the date of the liquidation of the Trust Account, if less than $10.00 per share due to reductions in the value of the trust assets,
less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed
a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to
any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including
liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed
to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims.
The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by
endeavoring to have vendors, service providers (except the Company’s independent registered public accounting firm), prospective
target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title,
interest or claim of any kind in or to monies held in the Trust Account. There can be no guarantee that the Company will be successful
in obtaining such waivers from its targeted vendors and service providers.
Liquidity and Capital Resources
As of March 31, 2021,
the Company had $1.8 million in its operating bank account and working capital of approximately $1.7 million.
The Company’s liquidity needs to date have been satisfied through
$25,000 paid by the Sponsor to cover certain expenses in exchange for the issuance of the Founder Shares, a loan of approximately $192,000
from the Sponsor pursuant to the Note (as defined in Note 5), and the proceeds from the consummation of the Private Placement not held
in the Trust Account of $2.5 million. The Company repaid the Note in full on March 30, 2021. As of March 31, 2021, the Company had an
advance due to related party of $22,760, which was paid in full on April 1, 2021. In addition, in order to finance transaction costs in
connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors
may, but are not obligated to, provide the Company Working Capital Loans (as defined in Note 5). As of March 31, 2021, there were no amounts
outstanding under any Working Capital Loan.
Based on the foregoing, management believes that
the Company will have sufficient working capital and borrowing capacity from the Sponsor or an affiliate of the Sponsor, or certain of
the Company’s officers and directors to meet its needs through the earlier of the consummation of a Business Combination or one
year from this filing. Over this time period, the Company will be using these funds for paying existing accounts payable, identifying
and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying
for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business
Combination
MSD ACQUISITION CORP.
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
Note 2 — Summary
of Significant Accounting Policies
Basis of Presentation
The accompanying unaudited condensed financial
statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”)
for financial information and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information
and footnotes required by GAAP. In the opinion of management, the unaudited condensed financial statements reflect all adjustments, which
include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. Operating
results for the period from February 5, 2021 (inception) through March 31, 2021 are not necessarily indicative of the results that may
be expected through December 31, 2021.
The accompanying unaudited
condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Current
Report on Form 8-K and the final prospectus filed by the Company with the SEC on April 2, 2021 and March 24, 2021, respectively.
In April 2021, the Company
identified an error in its accounting treatment for both its public and private warrants (Warrants) as presented in its audited balance
sheet as of March 29, 2021 included in its Current Report on Form 8-K, filed April 2, 2021. The Warrants were reflected as a component
of equity as opposed to liabilities on the balance sheet. Pursuant to FASB ASC Topic 250, Accounting Changes and Error Corrections,
and Staff Accounting Bulletin 99, “Materiality”) (“SAB 99”) issued by the SEC, the Company determined the impact of
the error was immaterial. The impact of the error correction is reflected in the unaudited condensed financial statements contained herein
which resulted in a $22.3 million increase to derivative liabilities and offsetting decrease to Class A ordinary shares subject to possible
redemption to the March 29, 2021 balance sheet. There was no impact to the Company’s financial position, net losses or cash flows.
Emerging Growth
Company
The Company is an “emerging growth company,”
as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”),
and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that
are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting
firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation
in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive
compensation and shareholder approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1) of the JOBS Act exempts
emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that
is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered
under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging
growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth
companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period,
which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company,
as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.
This may make comparison of the Company’s
financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted
out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
MSD ACQUISITION CORP.
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
Use of Estimates
The preparation of these financial statements
in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of
assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. Making estimates requires
management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation
or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate,
could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly
from those estimates.
Cash and Cash Equivalents
The Company considers
all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no
cash equivalents held outside the Trust Account as of March 31, 2021.
Investments Held in Trust Account
The Company’s portfolio of investments is
comprised solely of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a
maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities, or a combination thereof.
The Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the
balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities
is included in income from investments held in Trust Account in the accompanying unaudited condensed statement of operations. The estimated
fair values of investments held in the Trust Account are determined using available market information.
Concentration of Credit Risk
Financial instruments that potentially subject
the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal
Depository Insurance Coverage limit of $250,000 and investments held in Trust Account. As of March 31, 2021, the Company has not experienced
losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.
Fair Value of Financial Instruments
The fair value of the Company’s assets and
liabilities, which qualify as financial instruments under the FASB ASC Topic 820, “Fair Value Measurements and Disclosures,”
approximates the carrying amounts represented in the balance sheet.
Fair Value Measurements
Fair value is defined as the price that would
be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement
date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives
the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the
lowest priority to unobservable inputs (Level 3 measurements). These tiers include:
|
●
|
Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;
|
|
●
|
Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
|
|
●
|
Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
|
In some circumstances, the inputs used to measure
fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is
categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.
MSD ACQUISITION CORP.
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
Derivative Liabilities
The Company does not
use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial
instruments, including issued stock purchase warrants and forward purchase agreements, to determine if such instruments are derivatives
or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815-40, “Derivatives and Hedging
– Contracts in Entity’s Own Equity” (“ASC 815-40”). The classification of derivative instruments, including
whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.
The 11,500,000 warrants issued in connection with
the Initial Public Offering and exercise of the over-allotment (the “Public Warrants”) and the 9,333,333 Private Placement
Warrants are recognized as derivative liabilities in accordance with ASC 815-40. Accordingly, the Company recognizes the warrant instruments
as liabilities at fair value and adjusts the instruments to fair value at each reporting period. The liabilities are subject to re-measurement
at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s unaudited condensed statement
of operations. The estimated fair value of the Public Warrants is measured at fair value using a Monte Carlo simulation. The estimated
fair value of the Private Placement Warrants is measured at fair value using a Black-Scholes option pricing model.
The forward purchase agreement between the Company
and a certain investor, providing for the investor to purchase up to $50,000,000 of units, with each unit consisting of one Class A ordinary
share and one-fifth of one warrant to purchase one Class A ordinary share, at a purchase price of $10.00 per unit in a private placement
concurrently with the closing of the initial Business Combination, is recognized as a derivative liability in accordance with ASC 815-40.
Accordingly, the Company recognizes the instrument as a liability at fair value and with changes in fair value recognized in the Company’s
unaudited condensed statement of operations. The fair value of the forward purchase agreement is determined as the estimated unit value
less the net present value of the forward purchase agreement.
Class A Ordinary Shares Subject to
Possible Redemption
The Company accounts for its Class A ordinary
shares subject to possible redemption in accordance with the guidance in ASC 480. Class A ordinary shares subject to mandatory redemption
(if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including
Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon
the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times,
Class A ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption
rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly,
at March 31, 2021, 52,715,526 Class A ordinary shares subject to possible redemption are presented as temporary equity, outside of the
shareholders’ equity section of the Company’s unaudited condensed balance sheet.
Income Taxes
The Company complies with the accounting and reporting
requirements of FASB ASC Topic 740, “Income Taxes,” which prescribes a recognition threshold and a measurement attribute for
the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits
to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company’s
management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest
and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued
for interest and penalties as of March 31, 2021. The Company is currently not aware of any issues under review that could result in significant
payments, accruals or material deviation from its position.
There is currently no taxation imposed on income
by the Government of the Cayman Islands. In accordance with Cayman federal income tax regulations, income taxes are not levied on the
Company. Consequently, income taxes are not reflected in the Company’s financial statement. The Company’s management does
not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
MSD ACQUISITION CORP.
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
Net Income (Loss)
per Ordinary Share
Net income per ordinary share is computed by dividing
net income applicable to shareholders by the weighted average number of ordinary shares outstanding during the periods. The Company has
not considered the effect of the warrants sold in the Initial Public Offering and Private Placement to purchase an aggregate of 20,833,333
Class A ordinary shares in the calculation of diluted earnings per share, since their inclusion would be anti-dilutive under the treasury
stock method. As a result, diluted earnings per share is the same as basic earnings per share for the periods presented.
The Company’s statement of operations includes
a presentation of income per share for ordinary shares subject to redemption in a manner similar to the two-class method of income per
share. Net income per share, basic and diluted for Class A ordinary shares is calculated by dividing the income from investments held
in the Trust Account of $396, for the period from February 5, 2021 (inception) through March 31, 2021, by the weighted average number
of Class A ordinary shares outstanding for the period. Net income per share, basic and diluted for Class B ordinary shares for the period
from February 5, 2021 (inception) through March 31, 2021 is calculated by dividing the sum of all general and administration expenses
of approximately $140,000, noncash loss for a change in fair value of derivative liabilities of approximately $2.2 million and offering
costs associated with derivative liabilities of approximately $697,000, resulting in net loss of approximately $3.0 million, by the weighted
average number of Class B ordinary shares outstanding for the period.
Recent Accounting
Standards
In August 2020, the FASB
issued ASU No. 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts
in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity,
which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. The ASU also
removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception and
it also simplifies the diluted earnings per share calculation in certain areas. The Company early adopted the ASU on February 5,
2021 (inception). Adoption of the ASU did not impact the Company’s financial position, results of operations or cash flows.
Management does not believe
that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying
financial statements.
Note 3 — Initial
Public Offering
On March 29, 2021, the Company consummated its
Initial Public Offering of 57,500,000 Units, including 7,500,000 Over-Allotment Units, at $10.00 per Unit, generating gross proceeds of
$575.0 million, and incurring offering costs of approximately $33 million, of which approximately $20.1 million was for deferred underwriting
commissions.
Each Unit consists of one Class A ordinary share
and one-fifth of one redeemable warrant (“Public Warrant”). Each whole Public Warrant entitles the holder to purchase one
Class A ordinary share at an exercise price of $11.50 per share, subject to adjustment (see Note 7).
Note 4 — Private
Placement
Simultaneously with the closing of the Initial
Public Offering, the Company consummated the Private Placement of 9,333,333 Private Placement Warrants, at a price of $1.50 per Private
Placement Warrant with the Sponsor, generating gross proceeds of $14.0 million.
Each whole Private Placement Warrant is exercisable
for one whole Class A ordinary share at a price of $11.50 per share. A portion of the proceeds from the sale of the Private Placement
Warrants to the Sponsor was added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not
complete a Business Combination within the Combination Period, the Private Placement Warrants will expire worthless. The Private Placement
Warrants will be non-redeemable except as described below in Note 7 and exercisable on a cashless basis so long as they are held by the
Sponsor or its permitted transferees.
The Sponsor and the Company’s officers and
directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants until 30 days
after the completion of the initial Business Combination.
MSD ACQUISITION CORP.
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
Note 5 — Related
Party Transactions
Founder Shares
On February
11, 2021, the Sponsor paid an aggregate of $25,000 for certain offering expenses on behalf of the Company in exchange for issuance of
14,375,000 Class B ordinary shares (the “Founder Shares”). The Sponsor agreed to forfeit up to an aggregate of 1,875,000 Founder
Shares to the extent that the over-allotment option was not exercised in full by the underwriters, so that the Founder Shares would represent
20% of the Company’s issued and outstanding shares after the Initial Public Offering. On March 29, 2021, the underwriter fully exercised
its over-allotment option; thus, these 1,875,000 Founder Shares were no longer subject to forfeiture.
The Initial
Shareholders agreed not to transfer, assign or sell any of their Founder Shares until the earlier to occur of: (A) one year after the
completion of the initial Business Combination or earlier if, subsequent to the initial Business Combination, the closing price of the
Class A ordinary share equals or exceeds $12.00 per share (as adjusted for share sub-divisions, capitalization of shares, share dividends,
rights issuances, subdivisions reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period
commencing at least 150 days after the initial Business Combination, and (B) the date following the completion of the initial Business
Combination on which the Company completes a liquidation, merger, share exchange or other similar transaction that results in all of the
Company’s shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property.
Forward Purchase Agreement
On March 24, 2021, the Company entered into a
forward purchase agreement (the “Forward Purchase Agreement”) with the certain investor (the “Forward Purchase Investor”),
pursuant to which the Forward Purchase Investor agreed to purchase up to $50,000,000 of forward purchase units. Each forward purchase
unit (“Forward Purchase Unit”) will consist of one Class A ordinary share (the “Forward Purchase Shares”) and
one-fifth of one warrant to purchase one Class A ordinary share (the “Forward Purchase Warrants”), and will be sold at a purchase
price of $10.00 per Forward Purchase Unit in a private placement concurrently with the closing of the initial Business Combination. The
obligations of the Forward Purchase Investor under the Forward Purchase Agreement do not depend on whether any Class A ordinary shares
held by Public Shareholders are redeemed by the Company and the amount of Forward Purchase Units sold pursuant to the Forward Purchase
Agreement will be subject to the Forward Purchase Investor’s sole discretion. The proceeds from the sale of the Forward Purchase
Units may be used as part of the consideration to the sellers in the initial Business Combination, expenses in connection with the initial
Business Combination or for working capital in the post-transaction company. The Forward Purchase Shares will generally be identical to
the Class A ordinary shares included in the Units sold in the Initial Public Offering, except that they will be entitled to certain registration
rights. The Forward Purchase Warrants will have the same terms as the Private Placement Warrants so long as they are held by MSD Partners
or its permitted assignees and transferees.
Related Party Loans and Advances
On February 8, 2021, the Sponsor agreed to loan the Company up to $300,000
pursuant to a promissory note (the “Note”). The Note was non-interest bearing, unsecured and due upon the closing of the Initial
Public Offering. As of March 29, 2021, the Company borrowed approximately $192,000 under the Note. The Company repaid the Note in full
on March 30, 2021.
As of March 31, 2021, the Company had an advance due
to related party of $22,760, which was paid in full on April 1, 2021.
MSD ACQUISITION CORP.
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
In addition, in order to fund working capital
deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain
of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working
Capital Loans”). If the Company completes a Business Combination, the Company may repay the Working Capital Loans out of the proceeds
of the Trust Account released to the Company. Otherwise, the Working Capital Loans may be repaid only out of funds held outside the Trust
Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account
to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working
Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion,
up to $1.5 million of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of
$1.50 per warrant. The warrants would be identical to the Private Placement Warrants. Except for the foregoing, the terms of such Working
Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. As of March 31, 2021, the
Company had no borrowings under the Working Capital Loans.
Administrative Services Agreement
On March 24, 2021, the Company entered into an
agreement that provided that, commencing on the date that the Company’s securities were first listed on Nasdaq through the earlier
of consummation of the initial Business Combination or the liquidation, the Company agreed to pay the Sponsor up to $10,000 per month
for office space, administrative support and other services provided to members of the Company’s management team.
In addition, the Sponsor, officers and directors,
or any of their respective affiliates will be reimbursed for any out-of-pocket expenses incurred in connection with activities on the
Company’s behalf such as identifying potential target businesses and performing due diligence on suitable Business Combinations.
The audit committee will review on a quarterly basis all payments that were made by the Company to the Sponsor, officers or directors,
or the Company’s or their affiliates. Any such payments prior to an initial Business Combination will be made from funds held outside
the Trust Account.
Note 6 — Commitments
and Contingencies
Registration and Shareholder Rights
The holders of the Founder Shares, Private Placement
Warrants and warrants that may be issued upon conversion of Working Capital Loans (and any Class A ordinary shares issuable upon the exercise
of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans) were entitled to registration
rights pursuant to a registration and shareholder rights agreement signed upon the effective date of the Initial Public Offering. The
holders of these securities were entitled to make up to three demands, excluding short form demands, that the Company register such securities.
In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent
to the completion of the initial Business Combination. The Company will bear the expenses incurred in connection with the filing of any
such registration statements.
Underwriting Agreement
The Company granted the underwriters a 45-day
option from the date of this prospectus to purchase up to 7,500,000 additional Units at the Initial Public Offering price less the underwriting
discounts and commissions. On March 29, 2021, the underwriters fully exercised its over-allotment option.
The
underwriters were entitled to an underwriting discount of $0.20 per unit, or $11.5 million in the aggregate, paid upon the closing of
the Initial Public Offering. In addition, $0.35 per unit, or approximately $20.1 million in the aggregate will be payable to the underwriters
for deferred underwriting commissions. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account
solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.
Risks
and Uncertainties
Management
continues to evaluate the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that
the virus could have a negative effect on the Company’s financial position, results of its operations, and/or search for a target
company, the specific impact is not readily determinable as of the date of this financial statement. The financial statement does not
include any adjustments that might result from the outcome of this uncertainty.
MSD ACQUISITION CORP.
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
Note 7 — Shareholders’ Equity
Preference Shares — The Company
is authorized to issue 5,000,000 preference shares with a par value of $0.0001 per share. As of March 31, 2021, there were no preference
shares issued or outstanding.
Class A Ordinary Shares — The
Company is authorized to issue 500,000,000 Class A ordinary shares with a par value of $0.0001 per share. Holders of the Company’s
Class A ordinary shares are entitled to one vote for each share. As of March 31, 2021, there were 4,787,554 Class A ordinary shares issued
and outstanding, excluding 52,715,526 Class A ordinary shares subject to possible redemption.
Class B Ordinary Shares — The
Company is authorized to issue 50,000,000 Class B ordinary shares with a par value of $0.0001 per share. On February 11, 2021, the Company
issued 14,375,000 Class B ordinary shares. Of these, up to 1,875,000 Class B ordinary shares were subject to forfeiture to the Company
by the Initial Shareholders for no consideration to the extent that the underwriters’ over-allotment option was not exercised in
full or in part, so that the Class B ordinary shares would collectively represent 20% of the Company’s issued and outstanding ordinary
shares after the Initial Public Offering. On March 29, 2021, the underwriter fully exercised its over-allotment option; thus, these 1,875,000
Class B ordinary shares were no longer subject to forfeiture.
Ordinary shareholders of record are entitled to
one vote for each share held on all matters to be voted on by shareholders and holders of Class A ordinary shares and holders of Class
B ordinary shares will vote together as a single class on all matters submitted to a vote of the shareholders except as required by law;
provided that only holders of Class B ordinary shares will have the right to vote on the appointment of directors prior to or in connection
with the completion of the initial Business Combination.
The Class B ordinary shares will automatically
convert into Class A ordinary shares at the time of the consummation of the initial Business Combination on a one-for-one basis, subject
to adjustment for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like, and subject to further
adjustment. In the case that additional Class A ordinary shares or equity-linked securities are issued or deemed issued in connection
with the initial Business Combination, the number of Class A ordinary shares issuable upon conversion of all Founder Shares will equal,
in the aggregate, on an as-converted basis, 20% of the total number of Class A ordinary shares outstanding after such conversion (after
giving effect to any redemptions of Class A ordinary shares by Public Shareholders), including the total number of Class A ordinary shares
issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by
the Company in connection with or in relation to the consummation of the initial Business Combination, excluding any Class A ordinary
shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, or to be issued, to any seller
in the initial Business Combination and any Private Placement Warrants issued upon conversion of Working Capital Loans; provided that
such conversion of Founder Shares will never occur on a less than one-for-one basis.
MSD ACQUISITION CORP.
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
Note 8 — Warrants
As of March 31, 2021, there were 20,833,333 warrants
outstanding. Public Warrants may only be exercised for a whole number of shares. No fractional Public Warrants will be issued upon separation
of the Units and only whole Public Warrants will trade. The Public Warrants will become exercisable on the later of (a) 30 days after
the completion of a Business Combination and (b) 12 months from the closing of the Initial Public Offering; provided in each case that
the Company has an effective registration statement under the Securities Act covering the Class A ordinary shares issuable upon exercise
of the Public Warrants and a current prospectus relating to them is available and such shares are registered, qualified or exempt from
registration under the securities, or blue sky, laws of the state of residence of the holder (or the Company permit holders to exercise
their warrants on a cashless basis under certain circumstances). The Company agreed that as soon as practicable, but in no event later
than 15 business days after the closing of the initial Business Combination, the Company will use commercially reasonable efforts to file
with the SEC a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants and to maintain a current
prospectus relating to those Class A ordinary shares until the warrants expire or are redeemed, as specified in the warrant agreement.
If a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants is not effective by the 60th
day after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration
statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on
a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above,
if the Class A ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that they
satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option,
require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” and, in the event the Company
so elects, the Company will not be required to file or maintain in effect a registration statement, and in the event the Company does
not so elect, it will use commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent
an exemption is not available.
The warrants have an exercise price of $11.50
per share, subject to adjustments, and will expire five years after the completion of a Business Combination or earlier upon redemption
or liquidation. In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising
purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20
per Class A ordinary share (with such issue price or effective issue price to be determined in good faith by the board of directors and,
in the case of any such issuance to the Initial Shareholders or their affiliates, without taking into account any Founder Shares held
by the Initial Shareholders or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the
aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for
the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions),
and (z) the volume weighted average trading price of Class A ordinary shares during the 10-trading day period starting on the trading
day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is
below $9.20 per share, then the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher
of the Market Value and the Newly Issued Price, the $18.00 per share redemption trigger price will be adjusted (to the nearest cent) to
be equal to 180% of the higher of the Market Value and the Newly Issued Price, and the $10.00 per share redemption trigger price will
be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price See “— Redemption
of warrants when the price per class A ordinary share equals or exceeds $18.00” and “— Redemption of warrants when the
price per class A ordinary share equals or exceeds $10.00” as described below).
The Private Placement Warrants are identical to
the Public Warrants underlying the Units sold in the Initial Public Offering, except (i) that the Private Placement Warrants and the Class
A ordinary shares issuable upon exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days
after the completion of a Business Combination, subject to certain limited exceptions, (ii) except as described below, the Private Placement
Warrants will be non-redeemable so long as they are held by the Sponsor or such its permitted transferees and (iii) the Sponsor or its
permitted transferees will have the option to exercise the Private Placement Warrants on a cashless basis and have certain registration
rights. If the Private Placement Warrants are held by someone other than the Sponsor or its permitted transferees, the Private Placement
Warrants will be redeemable by the Company in all redemption scenarios and exercisable by such holders on the same basis as the Public
Warrants.
Redemption of warrants when the price per Class
A ordinary share equals or exceeds $18.00:
Once the warrants become exercisable, the Company
may call the outstanding warrants for redemption (except as described herein with respect to the Private Placement Warrants):
|
●
|
in whole and not in part;
|
|
|
|
|
●
|
at a price of $0.01 per warrant;
|
|
|
|
|
●
|
upon a minimum of 30 days’ prior written notice of
redemption to each warrant holder; and
|
|
|
|
|
●
|
if, and only if, the last reported sale price (the “closing
price”) of Class A ordinary shares equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within a 30-trading
day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.
|
The Company will not redeem the warrants as described
above unless a registration statement under the Securities Act covering the issuance of the Class A ordinary shares issuable upon exercise
of the warrants is then effective and a current prospectus relating to those Class A ordinary shares is available throughout the 30-day
redemption period.
MSD ACQUISITION CORP.
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
Redemption of warrants when the price per Class
A ordinary share equals or exceeds $10.00:
Once the warrants become exercisable, the Company
may call the outstanding warrants for redemption (except as described herein with respect to the Private Placement Warrants):
|
●
|
in whole and not in part;
|
|
|
|
|
●
|
at $0.10 per warrant upon a minimum of 30 days’ prior
written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and
receive that number of Class A ordinary shares to be determined by reference to an agreed table based on the redemption date and the
“fair market value” of Class A ordinary shares;
|
|
|
|
|
●
|
if, and only if, the closing price of Class A ordinary shares
equals or exceeds $10.00 per share (as adjusted) for any 20 trading days within the 30-trading day period ending three trading days before
the Company sends the notice of redemption to the warrant holders; and
|
|
|
|
|
●
|
if the closing price of the Class A ordinary shares for any
20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice
of redemption to the warrant holders is less than $18.00 per share (as adjusted), the Private Placement Warrants must also be concurrently
called for redemption on the same terms as the outstanding Public Warrants, as described above.
|
The “fair market value” of Class A
ordinary shares for the above purpose shall mean the volume weighted average price of Class A ordinary shares during the 10 trading days
immediately following the date on which the notice of redemption is sent to the holders of warrants. In no event will the warrants be
exercisable on a cashless basis in connection with this redemption feature for more than 0.361 Class A ordinary shares per warrant (subject
to adjustment).
If the Company is unable to complete a Business
Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not
receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held
outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.
Note 9 — Fair Value Measurements
The following table presents information about
the Company’s assets and liabilities that are measured at fair value on a recurring basis as of March 31, 2021 and indicates the
fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value.
Description
|
|
Quoted Prices in
Active Markets
(Level 1)
|
|
|
Significant Other
Observable Inputs
(Level 2)
|
|
|
Significant Other
Unobservable Inputs
(Level 3)
|
|
Assets:
|
|
|
|
|
|
|
|
|
|
Investments held in Trust Account - money market funds
|
|
$
|
575,000,396
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivative warrant liabilities - Public warrants
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
12,995,000
|
|
Derivative warrant liabilities - Private placement warrants
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
10,609,200
|
|
Forward purchase agreement
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
791,800
|
|
Transfers to/from Levels
1, 2, and 3 are recognized at the end of the reporting period. There were no transfers between levels of the fair value hierarchy during
the period ended March 31, 2021.
MSD ACQUISITION CORP.
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
Level 1 instruments include
investments in mutual funds invested in government securities. The Company uses inputs such as actual trade data, benchmark yields, quoted
market prices from dealers or brokers, and other similar sources to determine the fair value of its investments.
The estimated fair value
of the Public Warrants is measured at fair value using a Monte Carlo simulation. The estimated fair value of the Private Placement Warrants
is measured at fair value using a Black-Scholes option pricing model. The fair value of the forward purchase agreement is determined as
the estimated unit value less the net present value of the forward purchase agreement.
The estimated fair value
of the Public Warrants and the Private Placement Warrants is determined using Level 3 inputs. Inherent in a Monte Carlo simulation and
a Black-Scholes model are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend
yield. The Company estimates the volatility of its warrants based on implied volatility from the Company’s traded warrants and from
historical volatility of select peer company’s shares that matches the expected remaining life of the warrants. The risk-free interest
rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of
the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is
based on the historical rate, which the Company anticipates remaining at zero.
The following table
provides quantitative information regarding Level 3 fair value measurements inputs at their measurement dates:
|
|
March 29,
2021
|
|
|
March 31,
2021
|
|
Exercise price
|
|
$
|
11.50
|
|
|
$
|
11.50
|
|
Unit price
|
|
$
|
10.03
|
|
|
$
|
10.15
|
|
Volatility
|
|
|
10.0% - 20.0
|
%
|
|
|
10.0% - 20.0
|
%
|
Term (years)
|
|
|
6.0
|
|
|
|
6.0
|
|
Risk-free rate
|
|
|
1.13
|
%
|
|
|
1.16
|
%
|
The change in the fair
value of derivative liabilities, measured using Level 3 inputs, for the period ended March 31, 2021 is summarized as follows:
Derivative liabilities at March 29, 2021 (inception)
|
|
$
|
-
|
|
Issuance of derivative liabilities
|
|
|
22,262,530
|
|
Change in fair value of derivative liabilities
|
|
|
2,133,470
|
|
Derivative liabilities at March 31, 2021
|
|
$
|
24,396,000
|
|
Note 10 — Subsequent Events
Management has evaluated subsequent events and transactions that
occurred after the balance sheet date through the date the financial statements were available for issuance. Based upon this review, except
as noted above, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial
statements.
Item 2.
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations.
|
References to the “Company,” “MSD
Acquisition Corp.,” “MSD Acquisition,” “our,” “us” or “we” refer to MSD Acquisition
Corp. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction
with the unaudited interim condensed financial statements and the notes thereto contained elsewhere in this report. Certain information
contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.
Cautionary Note Regarding Forward-Looking Statements
This Quarterly Report on Form 10-Q includes
forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Exchange
Act. We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking
statements are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of
activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements
expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such
as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,”
“believe,” “estimate,” “continue,” or the negative of such terms or other similar expressions. Factors
that might cause or contribute to such a discrepancy include, but are not limited to, those described in our other SEC filings.
Overview
We are a blank check company incorporated as a
Cayman Islands exempted company on February 5, 2021. We were formed for the purpose of effecting a merger, share exchange, asset acquisition,
share purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). We
are an emerging growth company and, as such, we are subject to all of the risks associated with emerging growth companies.
Our sponsor is MSD Sponsor
Holdings, LLC, a Delaware limited liability company (“Sponsor”). The registration statement for our Initial Public Offering
was declared effective on March 24, 2021. On March 29, 2021, we consummated our Initial Public Offering of 57,500,000 units (the “Units”
and, with respect to the Class A ordinary shares included in the Units being offered, the “Public Shares”), including 7,500,000
additional Units to cover over-allotments (the “Over-Allotment Units”), at $10.00 per Unit, generating gross proceeds of $575.0
million, and incurring offering costs of approximately $33 million , of which approximately $20.1 million was for deferred underwriting
commissions (see Note 6).
Simultaneously with the
closing of the Initial Public Offering, we consummated the private placement (“Private Placement”) of 9,333,333 warrants (each,
a “Private Placement Warrant” and collectively, the “Private Placement Warrants”), at a price of $1.50 per Private
Placement Warrant with the Sponsor, generating gross proceeds of $14.0 million (see Note 4).
Upon the closing of Initial Public Offering and
the Private Placement, $575.0 million ($10.00 per Unit) of the net proceeds of the Initial Public Offering and certain of the proceeds
of the Private Placement were placed in a trust account (“Trust Account”) with Continental Stock Transfer & Trust Company
acting as trustee and will be invested in United States “government securities” within the meaning set forth in Section 2(a)(16)
of the Investment Company Act of 1940, as amended (the “Investment Company Act”), having a maturity of 185 days or less or
in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct
U.S. government treasury obligations, as determined by us, until the earlier of: (i) the completion of a Business Combination and (ii)
the distribution of the Trust Account as described below.
Our management has broad discretion with respect
to the specific application of the net proceeds of its Initial Public Offering and the sale of the Private Placement Warrants, although
substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. Our initial Business
Combination must be with one or more operating businesses or assets with a fair market value equal to at least 80% of the net assets held
in the Trust Account (excluding the deferred underwriting commissions and taxes payable on the income earned on the Trust Account) at
the time we sign a definitive agreement in connection with the initial Business Combination. However, we will only complete a Business
Combination if the post-Business Combination company owns or acquires 50% or more of the outstanding voting securities of the target business
or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment
company under the Investment Company Act.
If we are unable to complete a Business Combination
within the Combination Period, we will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible
but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate
amount then on deposit in the Trust Account, including interest (which interest shall be net of taxes payable and up to $100,000 of interest
to pay dissolution expenses), divided by the number of then issued and outstanding Public Shares, which redemption will completely extinguish
Public Shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any) and (iii)
as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the board of directors,
liquidate and dissolve, subject, in the case of clauses (ii) and (iii), to our obligations under Cayman Islands law to provide for claims
of creditors and in all cases subject to the other requirements of applicable law.
Liquidity and Capital Resources
As of March 31, 2021, we had approximately $1.8
million in our operating bank account and working capital of approximately $1.7 million.
Our liquidity needs to date have been satisfied through $25,000 paid by
our Sponsor to cover certain expenses in exchange for the issuance of the Founder Shares, a loan of approximately $192,000 from our Sponsor
pursuant to promissory note, and the proceeds from the consummation of the Private Placement not held in the Trust Account of $2.5 million.
We repaid the promissory note in full on March 30, 2021. As of March 31, 2021, the Company had an advance due to related party of $22,760,
which was paid in full on April 1, 2021. In addition, in order to finance transaction costs in connection with a Business Combination,
our Sponsor or an affiliate of our Sponsor, or certain of our officers and directors may, but are not obligated to, provide us Working
Capital Loans. As of March 31, 2021, there were no amounts outstanding under any Working Capital Loan.
Based on the foregoing, management believes that
we will have sufficient working capital and borrowing capacity from our Sponsor or an affiliate of our Sponsor, or certain of our officers
and directors to meet its needs through the earlier of the consummation of a Business Combination or one year from this filing. Over this
time period, we will be using these funds for paying existing accounts payable, identifying and evaluating prospective initial Business
Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target
business to merge with or acquire, and structuring, negotiating and consummating the Business Combination.
Management continues to evaluate the impact of
the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect
on our financial position, results of our operations and/or search for a target company, the specific impact is not readily determinable
as of the date of the financial statements. The financial statements do not include any adjustments that might result from the outcome
of this uncertainty.
Results of Operations
Our entire activity since inception up to March
31, 2021 was in preparation for our formation and the Initial Public Offering. We will not be generating any operating revenues until
the closing and completion of our initial Business Combination.
For the period from February 5, 2021 (inception)
through March 31, 2021, we had net loss of approximately $3.0 million, which primarily consisted of approximately $140,000 general and
administrative expenses, a noncash loss of approximately $2.2 million resulting from changes in fair value of derivative liabilities,
and a non-operating expense of approximately $697,000 related to offering costs for derivative liabilities.
Contractual Obligations
Registration and Shareholder Rights
The holders of the Founder Shares, Private Placement
Warrants and warrants that may be issued upon conversion of Working Capital Loans (and any Class A ordinary shares issuable upon the exercise
of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans) were entitled to registration
rights pursuant to a registration and shareholder rights agreement signed upon the effective date of the Initial Public Offering. The
holders of these securities were entitled to make up to three demands, excluding short form demands, that we register such securities.
In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent
to the completion of the initial Business Combination. We will bear the expenses incurred in connection with the filing of any such registration
statements.
Underwriting Agreement
We granted the underwriters a 45-day option from
the date of this prospectus to purchase up to 7,500,000 additional Units at the Initial Public Offering price less the underwriting discounts
and commissions. On March 29, 2021, the underwriter fully exercised its over-allotment option.
The underwriters were entitled to an underwriting
discount of $0.20 per unit, or $11.5 million in the aggregate, paid upon the closing of the Initial Public Offering. In addition, $0.35
per unit, or approximately $20.1 million in the aggregate will be payable to the underwriters for deferred underwriting commissions. The
deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that we complete a
Business Combination, subject to the terms of the underwriting agreement.
Critical Accounting Policies
Derivative Liabilities
We do not use derivative
instruments to hedge exposures to cash flow, market, or foreign currency risks. We evaluate all of our financial instruments, including
issued stock purchase warrants and forward purchase agreements, to determine if such instruments are derivatives or contain features that
qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815-40, “Derivatives and Hedging – Contracts in Entity’s
Own Equity” (“ASC 815-40”). The classification of derivative instruments, including whether such instruments should
be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.
The 11,500,000 warrants issued in connection with
the Initial Public Offering and exercise of the over-allotment (the “Public Warrants”) and the 9,333,333 Private Placement
Warrants are recognized as derivative liabilities in accordance with ASC 815-40. Accordingly, we recognize the warrant instruments as
liabilities at fair value and adjusts the instruments to fair value at each reporting period. The liabilities are subject to re-measurement
at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s statement of operations.
The estimated fair value of the Public Warrants is measured at fair value using a Monte Carlo simulation. The estimated fair value of
the Private Placement Warrants is measured at fair value using a Black-Scholes option pricing model.
The forward purchase agreement between the Company
and a certain investor, providing for the investor to purchase up to $50,000,000 of units, with each unit consisting of one Class A ordinary
share and one-fifth of one warrant to purchase one Class A ordinary share, at a purchase price of $10.00 per unit in a private placement
concurrently with the closing of the initial Business Combination, is recognized as a derivative liability in accordance with ASC 815-40.
Accordingly, the Company recognizes the instrument as a liability at fair value and with changes in fair value recognized in the Company’s
statement of operations. The fair value of the forward purchase agreement is determined as the estimated unit value less the net present
value of the forward purchase agreement.
Class A Ordinary Shares Subject to Possible
Redemption
We account for our Class A ordinary shares subject
to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Class A
ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally
redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control
of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control) are classified as temporary
equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. Our Class A ordinary shares feature
certain redemption rights that are considered to be outside of our control and subject to the occurrence of uncertain future events. Accordingly,
at March 31, 2021, 52,715,526 Class A ordinary shares subject to possible redemption are presented as temporary equity, outside of the
shareholders’ equity section of our balance sheet.
Net Income (Loss)
per Ordinary Share
Net income per ordinary share is computed by dividing
net income applicable to shareholders by the weighted average number of ordinary shares outstanding during the periods. We have not considered
the effect of the warrants sold in the Initial Public Offering and Private Placement to purchase an aggregate of 20,833,333 Class A ordinary
shares in the calculation of diluted earnings per share, since their inclusion would be anti-dilutive under the treasury stock method.
As a result, diluted earnings per share is the same as basic earnings per share for the periods presented.
Our statement of operations includes a presentation
of income per share for ordinary shares subject to redemption in a manner similar to the two-class method of income per share. Net income
per share, basic and diluted for Class A ordinary shares is calculated by dividing the income from investments held in the Trust Account
of $396, for the period from February 5, 2021 (inception) through March 31, 2021, by the weighted average number of Class A ordinary shares
outstanding for the period. Net income per share, basic and diluted for Class B ordinary shares for the period from February 5, 2021 (inception)
through March 31, 2021 is calculated by dividing the sum of all general and administration expenses of approximately $140,000, noncash
loss for a change in fair value of derivative liabilities of approximately $2.2 million and offering costs associated with derivative
liabilities of approximately $697,000, resulting in net loss of approximately $3.0 million, by the weighted average number of Class B
ordinary shares outstanding for the period.
Recent Accounting
Standards
In August 2020, the FASB
issued ASU No. 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts
in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity,
which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. The ASU also
removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception and
it also simplifies the diluted earnings per share calculation in certain areas. We early adopted the ASU on February 5, 2021 (inception). Adoption
of the ASU did not impact our financial position, results of operations or cash flows.
Our management does not
believe that any other recently issued, but not yet effective, accounting standards updates, if currently adopted, would have a material
effect on the accompanying financial statement.
Off-Balance Sheet Arrangements
As of March 31, 2021, we did not have any off-balance
sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation S-K.
JOBS Act
The Jumpstart Our Business Startups Act of 2012
(the “JOBS Act”) contains provisions that, among other things, relax certain reporting requirements for qualifying public
companies. We qualify as an “emerging growth company” and under the JOBS Act are allowed to comply with new or revised accounting
pronouncements based on the effective date for private (not publicly traded) companies. We are electing to delay the adoption of new or
revised accounting standards, and as a result, we may not comply with new or revised accounting standards on the relevant dates on which
adoption of such standards is required for non-emerging growth companies. As a result, the financial statements may not be comparable
to companies that comply with new or revised accounting pronouncements as of public company effective dates.
Additionally, we are in the process of evaluating
the benefits of relying on the other reduced reporting requirements provided by the JOBS Act. Subject to certain conditions set forth
in the JOBS Act, if, as an “emerging growth company,” we choose to rely on such exemptions we may not be required to, among
other things, (i) provide an auditor’s attestation report on our system of internal controls over financial reporting pursuant to
Section 404, (ii) provide all of the compensation disclosure that may be required of non-emerging growth public companies under the Dodd-Frank
Wall Street Reform and Consumer Protection Act, (iii) comply with any requirement that may be adopted by the PCAOB regarding mandatory
audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the financial statements
(auditor discussion and analysis) and (iv) disclose certain executive compensation related items such as the correlation between executive
compensation and performance and comparisons of the CEO’s compensation to median employee compensation. These exemptions will apply
for a period of five years following the completion of our Initial Public Offering or until we are no longer an “emerging growth
company,” whichever is earlier.